15 - 17 February, 2012, London, UK
Register by January 20 2012* and receive up to £200off!
Download the Info Pack
Access our Download Centre
Become a Pharma IQ Member and receive our weekly newsletter!
Connect to a global Pharma IQ social network
Learn more about sponsor & exhibit opportunities
Mark Your Calendar
Tell a Colleague
Laszlo Urban, Preclinical Safety ProfilingNIBR, Cambridge, Ma. presents: How To Mitigate Cardiac Toxicity During Lead Selection And Lead Optimization?
Paul Hastwell, Safety Assessment, GSK
Frank W Bonner, Stem Cell for Safer Medicines (SC4SM) presents: Exploring the Potential of Stem Cell Assays in Predictive Toxicology Testing
James A. Dykens, Investigative Toxicity Drug Safety Research & Development Sandwich, UK
Glyn Stacey, NIBSC-HPA presents: UK Stem Cell Bank: Supporting the Development of Stem Cell Models for Safety Testing.
M.B. Friedman, PhD, DABT Director of Toxicology
David R Jones, Expert Scientific Assessor (Pharmacotoxicologist), Licensing Division, Medicines and Healthcare products Regulatory Agency (MHRA), UK presents: Predictive Toxicology A Regulatory View
Vasily Dobrovolsky, Division of Genetic and Reproductive Toxicology, National Center for Toxicological Reasearch USFDA(DGRT/NCTR/FDA)
Director, Science & Technology
Sr Principal Scientist for ADME/Tox Services
Head of Exploratory Toxicology
Principal Scientist, Global Safety Assessment
SWP and CPWP
and Finnish Medicines Agency
Jorge Borr oto
Head of In Vivo Toxicology
Principal Scientist, Molecular Toxicology
Jens-Uwe Peters Principle ScientistRoche
Manfred Kansy Associate DirectorRoche
Laboratory for Regenerative Medicine
University of Cambridge
New Directions in Drug Discovery: the Application of Embryonic Stem Cells
This session will see the pro’s and con’s of the practical application of embryonic stem cells in drug discovery debated, as well as the ethical and regulatory challenges, including the recent ECJ decision. Be prepared to ask questions and get involved with the debate!
Laszlo Urban Executive Director Novartis
[ Register Now ]
Questions? Contact us on 0800 652 2363 or +44 (0) 20 7368 9300 or email firstname.lastname@example.org now!